sability of the biomarker Midregional-proAdrenomedullin in children with congenital heart defect and surgical operation with use of a heart lung machine
- Conditions
- Q21Congenital malformations of cardiac septa
- Registration Number
- DRKS00023663
- Lead Sponsor
- niversita¨tsklinikum Heidelberg Zentrum fu¨r Kinder- und Jugendmedizin Kinderheilkunde II – Pa¨diatrische Kardiologie & Angeborene Herzfehler
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Written and signed informed consent by the parents
Congential heart defect
elective corective surgery with use of a heart lung machine
5th day of live up to 18 years
Exclusion Criteria
Non-Compliance to the including criteria’s
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sability of the biomarkers MR-proADM for the prediction of an infection in patients following a surgical correction of a congenital heart defect with use of a heart-lung machine will be determined. Therefore, routinely collect microbiological findings as well as plasmatic inflammation parameters will be collected and compared with the measured values of MR-proADM
- Secondary Outcome Measures
Name Time Method Attempt to correlate the measured values of MR-proADM with the intensive care unit stay of the recruited patients.